-
Vitamin B12 was effective in the treatment of recurrent aphthous stomatitis.
-
The FDA has approved another selective serotonin and norepinephrine reuptake inhibitor for the management of fibromyalgia (FM).
-
Actinic keratoses (AK) areat bestprecancerous skin lesions, and at worst (a belief held by many leaders in the skin cancer field), skin carcinoma in situ.
-
In a longitudinal population-based study, metformin use was associated with an increased incidence of low thyroid-stimulating hormone (TSH) levels in patients with treated hypothyroidism.
-
An objective, laboratory based diagnostic tool for depression would be extremely helpful to primary care physicians. This study using nine biomarkers holds promise that a blood test may be able to identify depressed patients among non-depressed primary care patients
-
Expanding upon their earlier study that demonstrated that spouses of hypertensive patients are more likely to be hypertensive themselves, these British researchers studied couples to determine whether other illnesses exhibited the same association.
-
Among patients being evaluated for chronic cough, women are more sensitive than men to inhalation of tussive agents.
-
GlaxoSmithKline is expected to launch a new drug for benign prostatic hypertrophy in December. Dutasteride is a 5 alpha-reductase inhibitor, which was previously approved in November 2001 but not launched.
-
Debate over the cardiovascular effects of COX-2 inhibitors has raged
for more than a year since a special communication was published in
JAMA last August suggesting an increase in cardiovascular events with
rofecoxib (Vioxx). Now a large retrospect, the cohort study from the
Tennessee Medicaid program seems to confirm the prothrombotic effects
of rofecoxib, at least in high dose.
-
This study assessed the effectiveness of oral melatonin taken in different dosage regimens for alleviating jet-lag after air travel across several time zones.
